<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" ><generator uri="https://jekyllrb.com/" version="3.9.3">Jekyll</generator><link href="https://reimandlab.org/feed.xml" rel="self" type="application/atom+xml" /><link href="https://reimandlab.org/" rel="alternate" type="text/html" /><updated>2023-10-14T18:56:20+00:00</updated><id>https://reimandlab.org/feed.xml</id><title type="html">Reimand Lab</title><subtitle>The Reimand lab works on computational biology and cancer research at the Ontario Institute for Cancer Research and University of Toronto. We are located at the MaRS Centre in Toronto, Canada. </subtitle><author><name>Reimand Lab</name></author><entry><title type="html">Diogo ICSB 2023 Presentation</title><link href="https://reimandlab.org/news/Diogo_ICSB_2023/" rel="alternate" type="text/html" title="Diogo ICSB 2023 Presentation" /><published>2023-10-13T00:00:00+00:00</published><updated>2023-10-13T00:00:00+00:00</updated><id>https://reimandlab.org/news/Diogo_ICSB_2023</id><content type="html" xml:base="https://reimandlab.org/news/Diogo_ICSB_2023/">&lt;p&gt;Diogo Pellegrina gave a talk at the International Conference on Systems Biology in Hartford (CT, USA). Diogo presented his recent work on human genetic variation and phospho-signalling networks in the context of COVID-19 using datasets from the HostSeq project.&lt;/p&gt;</content><author><name>Reimand Lab</name></author><category term="news" /><category term="team" /><summary type="html">Diogo Pellegrina gave a talk at the International Conference on Systems Biology in Hartford (CT, USA). Diogo presented his recent work on human genetic variation and phospho-signalling networks in the context of COVID-19 using datasets from the HostSeq project.</summary></entry><entry><title type="html">Awards to Masroor Bayati</title><link href="https://reimandlab.org/news/Masroor_Bayati_Awards/" rel="alternate" type="text/html" title="Awards to Masroor Bayati" /><published>2023-08-13T00:00:00+00:00</published><updated>2023-08-13T00:00:00+00:00</updated><id>https://reimandlab.org/news/Masroor_Bayati_Awards</id><content type="html" xml:base="https://reimandlab.org/news/Masroor_Bayati_Awards/">&lt;p&gt;Congratulations to Masroor Bayati (Reimand lab) who was awarded the 2023-2024 MBP Excellence Award by the department of Medical Biophysics at the University of Toronto, and the MBP Caven Fellowship award.&lt;/p&gt;</content><author><name>Reimand Lab</name></author><category term="news" /><category term="awards" /><summary type="html">Congratulations to Masroor Bayati (Reimand lab) who was awarded the 2023-2024 MBP Excellence Award by the department of Medical Biophysics at the University of Toronto, and the MBP Caven Fellowship award.</summary></entry><entry><title type="html">Award to Alec Bahcheli</title><link href="https://reimandlab.org/news/Alec_Bahcheli_Award/" rel="alternate" type="text/html" title="Award to Alec Bahcheli" /><published>2023-07-11T00:00:00+00:00</published><updated>2023-07-11T00:00:00+00:00</updated><id>https://reimandlab.org/news/Alec_Bahcheli_Award</id><content type="html" xml:base="https://reimandlab.org/news/Alec_Bahcheli_Award/">&lt;p&gt;Congratulations to Alec Bahcheli (Reimand lab) who was awarded the 2023-2024 Ontario Graduate Scholarship at the University of Toronto, department of Molecular Genetics.&lt;/p&gt;</content><author><name>Reimand Lab</name></author><category term="news" /><category term="awards" /><summary type="html">Congratulations to Alec Bahcheli (Reimand lab) who was awarded the 2023-2024 Ontario Graduate Scholarship at the University of Toronto, department of Molecular Genetics.</summary></entry><entry><title type="html">Masroor and Kevin GLBIO 2023 Poster Presentation</title><link href="https://reimandlab.org/news/GLBIO_poster_2023/" rel="alternate" type="text/html" title="Masroor and Kevin GLBIO 2023 Poster Presentation" /><published>2023-06-06T00:00:00+00:00</published><updated>2023-06-06T00:00:00+00:00</updated><id>https://reimandlab.org/news/GLBIO_poster_2023</id><content type="html" xml:base="https://reimandlab.org/news/GLBIO_poster_2023/">&lt;p&gt;Masroor Bayati and Kevin Cheng gave a poster presentation at the GLBIO conference 2023 in Montreal from May 16th to 18th, 2023. Masroor’s poster title: Systematic pan-cancer analysis to reveal the prognostic significance of driver mutations and the tumor immune microenvironment. Kevin’s poster title: Treatment-associated mutation rate variation in regulatory elements in metastatic cancer genomes.&lt;/p&gt;</content><author><name>Reimand Lab</name></author><category term="news" /><category term="team" /><summary type="html">Masroor Bayati and Kevin Cheng gave a poster presentation at the GLBIO conference 2023 in Montreal from May 16th to 18th, 2023. Masroor’s poster title: Systematic pan-cancer analysis to reveal the prognostic significance of driver mutations and the tumor immune microenvironment. Kevin’s poster title: Treatment-associated mutation rate variation in regulatory elements in metastatic cancer genomes.</summary></entry><entry><title type="html">Publication: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer</title><link href="https://reimandlab.org/news/research_article_in_nature_communications/" rel="alternate" type="text/html" title="Publication: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer" /><published>2023-06-06T00:00:00+00:00</published><updated>2023-06-06T00:00:00+00:00</updated><id>https://reimandlab.org/news/research_article_in_nature_communications</id><content type="html" xml:base="https://reimandlab.org/news/research_article_in_nature_communications/">&lt;p&gt;Nina Adler and Jüri Reimand collaborated with Dzana Dervovic and Daniel Schramek at the Lunenfeld-Tanenbaum Research Institute and UofT Department of Molecular Genetics on the systematic discovery of the regulators of immune therapy response in lung cancer. Nina led integrative pathway enrichment analyses to interpret the functional roles of the identified target genes in human lung cancers. The study was published this week in &lt;a href=&quot;https://www.nature.com/articles/s41467-023-38841-7&quot; target=&quot;_blank&quot;&gt;Nature Communications&lt;/a&gt;.&lt;/p&gt;</content><author><name>Reimand Lab</name></author><category term="news" /><category term="publications" /><summary type="html">Nina Adler and Jüri Reimand collaborated with Dzana Dervovic and Daniel Schramek at the Lunenfeld-Tanenbaum Research Institute and UofT Department of Molecular Genetics on the systematic discovery of the regulators of immune therapy response in lung cancer. Nina led integrative pathway enrichment analyses to interpret the functional roles of the identified target genes in human lung cancers. The study was published this week in Nature Communications.</summary></entry><entry><title type="html">Publication: Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing</title><link href="https://reimandlab.org/news/research_article_in_frontiers/" rel="alternate" type="text/html" title="Publication: Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing" /><published>2023-05-23T00:00:00+00:00</published><updated>2023-05-23T00:00:00+00:00</updated><id>https://reimandlab.org/news/research_article_in_frontiers</id><content type="html" xml:base="https://reimandlab.org/news/research_article_in_frontiers/">&lt;p&gt;Diogo Pellegrina co-led a collaboration with Dr. Mamatha Bhat (UHN) on the transcriptomic analysis of post-transplant liver disease that revealed dysregulation of wound healing pathways. The study was published this week in  &lt;a href=&quot;https://doi.org/10.3389/fendo.2023.1111614&quot; target=&quot;_blank&quot;&gt;Frontiers in Endocrinology&lt;/a&gt;. We profiled the transcriptomes of livers with post-transplant nonalcoholic steatohepatitis (PT-NASH) from liver transplant recipients to identify dysregulated genes, pathways, and molecular interaction networks.&lt;/p&gt;</content><author><name>Reimand Lab</name></author><category term="news" /><category term="publications" /><summary type="html">Diogo Pellegrina co-led a collaboration with Dr. Mamatha Bhat (UHN) on the transcriptomic analysis of post-transplant liver disease that revealed dysregulation of wound healing pathways. The study was published this week in Frontiers in Endocrinology. We profiled the transcriptomes of livers with post-transplant nonalcoholic steatohepatitis (PT-NASH) from liver transplant recipients to identify dysregulated genes, pathways, and molecular interaction networks.</summary></entry><entry><title type="html">New preprint: Pan-cancer analysis of the ion permeome reveals functional regulators of glioblastoma aggression</title><link href="https://reimandlab.org/news/preprint_published_in_bioRxiv/" rel="alternate" type="text/html" title="New preprint: Pan-cancer analysis of the ion permeome reveals functional regulators of glioblastoma aggression" /><published>2023-05-05T00:00:00+00:00</published><updated>2023-05-05T00:00:00+00:00</updated><id>https://reimandlab.org/news/preprint_published_in_bioRxiv</id><content type="html" xml:base="https://reimandlab.org/news/preprint_published_in_bioRxiv/">&lt;p&gt;We posted a new preprint on &lt;a href=&quot;https://doi.org/10.1101/2023.04.07.536030&quot; target=&quot;_blank&quot;&gt;bioRxiv&lt;/a&gt;. Our integrative pan-cancer analysis shows that IP genes display highly-elevated expression patterns in subsets of cancer samples significantly more often than expected transcriptome-wide. To enable target identification, we identified 410 survival-associated IP genes in 29 cancer types using a machine learning approach.&lt;/p&gt;</content><author><name>Reimand Lab</name></author><category term="news" /><category term="publications" /><summary type="html">We posted a new preprint on bioRxiv. Our integrative pan-cancer analysis shows that IP genes display highly-elevated expression patterns in subsets of cancer samples significantly more often than expected transcriptome-wide. To enable target identification, we identified 410 survival-associated IP genes in 29 cancer types using a machine learning approach.</summary></entry><entry><title type="html">Mykhaylo CSHL 2023 Poster Presentation</title><link href="https://reimandlab.org/news/Mykhaylo_CSHL_2023/" rel="alternate" type="text/html" title="Mykhaylo CSHL 2023 Poster Presentation" /><published>2023-04-05T00:00:00+00:00</published><updated>2023-04-05T00:00:00+00:00</updated><id>https://reimandlab.org/news/Mykhaylo_CSHL_2023</id><content type="html" xml:base="https://reimandlab.org/news/Mykhaylo_CSHL_2023/">&lt;p&gt;Mykhaylo Slobodyanyuk (Reimand lab) gave a poster presentation at the 8th Cold Spring Harbor Laboratory meeting in NY (USA) on March 16, 2023. Poster title: Direction-aware data fusion techniques for multi-omics pathway and network analysis and biomarker discovery.&lt;/p&gt;</content><author><name>Reimand Lab</name></author><category term="news" /><category term="team" /><summary type="html">Mykhaylo Slobodyanyuk (Reimand lab) gave a poster presentation at the 8th Cold Spring Harbor Laboratory meeting in NY (USA) on March 16, 2023. Poster title: Direction-aware data fusion techniques for multi-omics pathway and network analysis and biomarker discovery.</summary></entry><entry><title type="html">New preprint: Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes</title><link href="https://reimandlab.org/news/preprint_published_in_biorxiv/" rel="alternate" type="text/html" title="New preprint: Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes" /><published>2023-04-05T00:00:00+00:00</published><updated>2023-04-05T00:00:00+00:00</updated><id>https://reimandlab.org/news/preprint_published_in_biorxiv</id><content type="html" xml:base="https://reimandlab.org/news/preprint_published_in_biorxiv/">&lt;p&gt;We posted a new preprint on &lt;a href=&quot;https://doi.org/10.1101/2023.03.19.533271&quot; target=&quot;_blank&quot;&gt;bioRxiv&lt;/a&gt;. We analysed the protein-coding impact of single base substitution signatures in 12,341 cancer genomes from 18 cancer types. Stop-gain mutations (SGMs) were strongly enriched in the signatures of tobacco smoking, APOBEC cytidine deaminases, and reactive oxygen species. Our study exposes SGM expansion as a genetic mechanism by which endogenous and carcinogenic mutational processes contribute to protein loss-of-function, oncogenesis, and tumor heterogeneity, providing potential translational and mechanistic insights.&lt;/p&gt;</content><author><name>Reimand Lab</name></author><category term="news" /><category term="publications" /><summary type="html">We posted a new preprint on bioRxiv. We analysed the protein-coding impact of single base substitution signatures in 12,341 cancer genomes from 18 cancer types. Stop-gain mutations (SGMs) were strongly enriched in the signatures of tobacco smoking, APOBEC cytidine deaminases, and reactive oxygen species. Our study exposes SGM expansion as a genetic mechanism by which endogenous and carcinogenic mutational processes contribute to protein loss-of-function, oncogenesis, and tumor heterogeneity, providing potential translational and mechanistic insights.</summary></entry><entry><title type="html">Congratulations to Diogo Pellegrina</title><link href="https://reimandlab.org/news/Diogo-Pellegrina-Congratulations/" rel="alternate" type="text/html" title="Congratulations to Diogo Pellegrina" /><published>2023-01-23T00:00:00+00:00</published><updated>2023-01-23T00:00:00+00:00</updated><id>https://reimandlab.org/news/Diogo-Pellegrina-Congratulations</id><content type="html" xml:base="https://reimandlab.org/news/Diogo-Pellegrina-Congratulations/">&lt;p&gt;Congratulations to Diogo Pellegrina (Reimand lab) who received a postdoctoral STAGE HostSeq Project fellowship to continue studying the role of human genetic variation and signalling networks in the context of SARS-CoV-2 infection and COVID-19 in Canadians.&lt;/p&gt;</content><author><name>Reimand Lab</name></author><category term="news" /><category term="awards" /><summary type="html">Congratulations to Diogo Pellegrina (Reimand lab) who received a postdoctoral STAGE HostSeq Project fellowship to continue studying the role of human genetic variation and signalling networks in the context of SARS-CoV-2 infection and COVID-19 in Canadians.</summary></entry></feed>